Completed PHASE3 INTERVENTIONAL 4-arm NCT00860873

Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis

Randomized Study of Two Dosage Forms (Oral Powder and Capsule) of Chondroitin + Glucosamine Sulfate Produced by the Laboratory EMS When Compared to the Product Condroflex (Oral Powder and Capsules) Produced by Laboratory Zodiac in the Treatment of Osteoarthrosis.

Sponsor: Azidus Brasil

Conditions Osteoarthrosis

Interventions EMS Chondroitin Sulfate + Glucosamine Sulfate (Oral powder) EMS Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (hard capsules) Zodiac Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (hard capsules) Zodiac: Chondroitin Sulfate 1200mg + Glucosamine Sulfate 1500mg (Oral powder)

Updated 5 times since 2017 Last updated: Feb 22, 2013 Started: Oct 31, 2009 Primary completion: Nov 30, 2009 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00860873, this PHASE3 trial focuses on Osteoarthrosis and remains completed. Sponsored by Azidus Brasil, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azidus Brasil

Data source: Azidus Brasil

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valinhos, Brazil